Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,856 | -30,375 | -18,448 | -29,893 | -13,541 |
| Depreciation Amortization | 5,965 | 30,480 | 24,563 | 18,769 | 9,384 |
| Accounts receivable | 58,583 | -65,990 | -87,187 | -6,970 | -12,172 |
| Other Working Capital | 20,321 | -45,333 | -20,489 | 4,468 | -10,099 |
| Other Operating Activity | -57,450 | 83,036 | 103,347 | 20,179 | 13,890 |
| Operating Cash Flow | $8,563 | $-28,182 | $1,786 | $6,553 | $-12,538 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,110 | -3,814 | -5,513 | -1,701 | -2,935 |
| Net Acquisitions | N/A | -8,174 | -8,174 | -8,174 | N/A |
| Investing Cash Flow | $15,110 | $-11,988 | $-13,687 | $-9,875 | $-2,935 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -189 | -189 | -187 | -180 | -111 |
| Financing Cash Flow | $-189 | $-189 | $-187 | $-180 | $-111 |
| Beginning Cash Position | 10,229 | 50,588 | 50,588 | 50,588 | 50,588 |
| End Cash Position | 33,713 | 10,229 | 38,500 | 47,086 | 35,004 |
| Net Cash Flow | $23,484 | $-40,359 | $-12,088 | $-3,502 | $-15,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,563 | -28,182 | 1,786 | 6,553 | -12,538 |
| Free Cash Flow | 8,563 | -28,182 | 1,786 | 6,553 | -12,538 |